Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

1.3K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.3K
Gene Therapy00:59

Gene Therapy

27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.1K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K
Bacterial Transformation01:33

Bacterial Transformation

60.1K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
60.1K
Metal-Ligand Bonds02:51

Metal-Ligand Bonds

24.4K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
24.4K
Qualitative Analysis03:46

Qualitative Analysis

24.5K
For solutions containing mixtures of different cations, the identity of each cation can be determined by qualitative analysis. This technique involves a series of selective precipitations with different chemical reagents, each reaction producing a characteristic precipitate for a specific group of cations. Metal ions within a group are further separated by varying the pH, heating the mixture to redissolve a precipitate, or adding other reagents to form complex ions.
For instance, group IV...
24.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High prevalence of vascular calcification in young stroke patients.

American journal of preventive cardiology·2026
Same author

The Fast and the Fragile: Neurosurgical Trauma in the Age of Micromobility.

Neurosurgery·2026
Same author

Comparative Accuracy of TCD, TTE, TEE, and Cardiac CT in Detecting Right-to-Left Shunt in Embolic Stroke of Undetermined Source.

Neurology. Clinical practice·2026
Same author

Machine learning-based prediction of long-term new-onset diabetes mellitus risk after pancreaticoduodenectomy using radiomics.

Digital health·2026
Same author

Identifying predictive proteomic biomarkers of selective serotonin reuptake inhibitor treatment effect in depression.

Biomarkers in medicine·2026
Same author

Gastric Ultrasound Utility in Predicting Stomach Contents in Patients with Upper Gastrointestinal Bleeding.

Journal of intensive care medicine·2026

Related Experiment Video

Updated: Feb 8, 2026

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.5K

To Treat or Not to Treat?

Steven R Levine1,2, Sarah Z Weingast3, Jeremy Weedon4

  • 1From the Departments of Neurology and Emergency Medicine (S.R.L.).

Stroke
|July 7, 2018
PubMed
Summary
This summary is machine-generated.

Physician decisions on alteplase treatment for minor stroke are complex. Four key factors like prior hemorrhage and anticoagulation use explain less than 15% of treatment variability.

Keywords:
contraindicationsdecision makingphysiciansprobabilitystroketissue plasminogen activator

More Related Videos

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

19.3K
Preparation of 2-dGuo-Treated Thymus Organ Cultures
07:50

Preparation of 2-dGuo-Treated Thymus Organ Cultures

Published on: August 28, 2008

15.0K

Related Experiment Videos

Last Updated: Feb 8, 2026

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.5K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

19.3K
Preparation of 2-dGuo-Treated Thymus Organ Cultures
07:50

Preparation of 2-dGuo-Treated Thymus Organ Cultures

Published on: August 28, 2008

15.0K

Area of Science:

  • Neurology
  • Clinical Medicine
  • Health Services Research

Background:

  • The 2015 US FDA alteplase (tPA) label update modified contraindications for stroke treatment.
  • Alteplase is a critical thrombolytic therapy for acute ischemic stroke.

Purpose of the Study:

  • To investigate clinical factors influencing alteplase treatment decisions in patients with minor stroke.
  • To quantify the impact of specific patient characteristics on physician treatment choices.

Main Methods:

  • An expert panel identified 7 key clinical factors for survey vignettes.
  • A fractional factorial design generated 150 unique patient vignettes.
  • 194 US physicians (neurologists, emergency physicians) rated treatment likelihood on a 0-5 scale.
  • Conjoint statistical analysis evaluated the relative importance of each factor.

Main Results:

  • Treatment likelihood varied widely (6% to 95%) across vignettes.
  • National Institutes of Health Stroke Scale (NIHSS) score positively correlated with treatment probability (24% for NIHSS=1 vs. 41% for NIHSS=5).
  • Four factors—prior intracerebral hemorrhage (18%), recent anticoagulation (17%), NIHSS (13%), and prior ischemic stroke (10%)—accounted for 58% of the model's relative importance.

Conclusions:

  • Four main variables explain less than 15% of the total variance in alteplase treatment decisions for minor stroke.
  • High variability suggests significant complexity and potential for unmeasured factors influencing treatment.
  • Future research should explore additional variables, including physician-specific characteristics, to better understand treatment disparities.